Lushang Freda Pharmaceutical Co., Ltd. Class ASSE: 600223

Announcement on Convening the 2025 Annual Performance Briefing

· Issued by Lushang Freda Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening the 2025 Annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Lushang Freda Pharmaceutical Co., Ltd. Class A

All Lushang Freda Pharmaceutical Co., Ltd. Class A news releases